The Non-Opioids Prevent Addiction in the Nation Act (“NOPAIN Act”) is a bipartisan piece of legislation designed to increase patient and provider access to non-opioid approaches to acute pain management. This innovative piece of federal legislation is designed to better incentivize the utilization of non-opioid pain management approaches by improving insurance coverages for these therapies.
Currently, outdated federal reimbursement policies provide economic disincentives for utilizing non-opioid approaches for acute pain patients. The NOPAIN Act addresses this challenge and, in the process, will make non-opioid acute pain approaches more readily available to millions of American patients who undergo a surgical procedure each year. By doing so, the legislation aims to minimize unnecessary levels of exposure to opioids and reduce the likelihood of opioid misuse following an acute pain incident.
The NOPAIN Act was first introduced in the 116th Congress and gained over 80 bipartisan cosponsors in both chambers.